Anthera

Enthera Pharmaceuticals

This biotech company develops monoclonal antibodies and fusion proteins for patients with autoimmune conditions including type 1 diabetes and inflammatory bowel disease.

Alnara

The company develops protein therapeutics to treat metabolic diseases, such as exocrine pancreatic insufficiency, for patients with conditions including cystic fibrosis and chronic pancreatitis.

FF Pharmaceuticals

This company develops monoclonal antibody therapeutics to treat inflammatory and autoimmune diseases for patients with conditions such as Crohn's disease.

AgomAb Therapeutics

This biopharmaceutical company develops therapies to treat fibrotic and inflammatory diseases for patients with conditions such as Crohn's disease and pulmonary fibrosis.

Zenas

This biopharmaceutical company develops and commercialises immunology-based therapies for patients with autoimmune diseases and rare fibroinflammatory conditions.

SFA Theraputics

This biopharmaceutical company develops oral small-molecule drugs for patients suffering from autoimmune diseases, chronic inflammatory conditions, and various types of liver cancer.

OxThera AB

This biopharmaceutical company develops bacteria-based therapies to treat patients with primary hyperoxaluria and other rare kidney diseases.

InflaRx

This biopharmaceutical company develops anti-inflammatory inhibitors for hospitals to treat patients with life-threatening autoimmune and inflammatory conditions.